Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
8.07
+0.20 (2.54%)
At close: May 29, 2025, 4:00 PM
8.08
+0.01 (0.12%)
After-hours: May 29, 2025, 4:39 PM EDT
Journey Medical Employees
Journey Medical had 41 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
41
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,371,780
Profits / Employee
-$202,512
Market Cap
186.45M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41 | 0 | - |
| Dec 31, 2023 | 41 | 21 | 105.00% |
| Dec 31, 2022 | 20 | -70 | -77.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
DERM News
- 15 days ago - Journey Medical Corporation (DERM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 22 days ago - Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 - GlobeNewsWire
- 7 weeks ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 2 months ago - Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer - GlobeNewsWire
- 2 months ago - Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea - GlobeNewsWire